Rong and associates (2017) discovered that using the human neuroblastoma cell line, SK-N-SH, NDRG2 modulates amyloid precursor protein (APP) processing, leading to an increase of amyloid β (Aβ) peptides via the BACE1 and GGA3 pathways (51). The gene discussed is APP; the disease is neuroblastoma.